# ACAPHA in Preventing Lung Cancer in Former Smokers With Bronchial Intraepithelial Neoplasia

> **NCT00522197** · PHASE2 · COMPLETED · sponsor: **British Columbia Cancer Agency** · enrollment: 90 (actual)

## Conditions studied

- Lung Cancer
- Precancerous Condition

## Interventions

- **DIETARY_SUPPLEMENT:** multi-herbal agent ACAPHA
- **DIETARY_SUPPLEMENT:** Sugar Pill

## Key facts

- **NCT ID:** NCT00522197
- **Lead sponsor:** British Columbia Cancer Agency
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-09
- **Primary completion:** 2008-10
- **Final completion:** 2008-11
- **Target enrollment:** 90 (ACTUAL)
- **Last updated:** 2012-03-09

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00522197

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00522197, "ACAPHA in Preventing Lung Cancer in Former Smokers With Bronchial Intraepithelial Neoplasia". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT00522197. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*